Company: CXDO
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001654954-25-002287
Chunk: 702

Company: Crexendo, Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 4
Chunk 702
---
 December 31, 2024  305,834   5.21  The weighted-average grant-date fair value of RSUs granted during the years ended December 31, 2024 and 2023 was $5.24 and $1.87, respectively.  The total intrinsic value of RSUs that vested and were released during the years ended December 31, 2024 and 2023 was $480 and $793 respectively. As of December 31, 2024, the total future compensation expense related to non-vested RSUs not yet recognized in the consolidated statements of operations was approximately $1,542 and the weighted-average period over which these awards are expected to be recognized is approximately 1.1 year. The following table summarizes the statement of operations effect of stock-based compensation for the years ended December 31, 2024 and 2023 (in thousands):    Year Ended December 31,   2024  2023 Share-based compensation expense by type:      Stock options $2,399  $3,221 Restricted stock units  603   628 Total cost related to share-based compensation expense $3,002  $3,849 Share-based compensation expense by financial statement line item:        Cost of revenue $476  $582 Research and development  611   610 Selling and marketing  548   658 General and administrative  1,367   1,999 Total cost related to share-based compensation expense $3,002  $3,849  The tax benefit related to stock compensation expense on net deferred tax assets at December 31, 2024 and 2023 was $812 and $747, respectively. 

 73Table of Contents

15. Income Taxes The income tax benefit/(provision) consisted of the following for the years ended December 31, 2024 and 2023 (in thousands):     Year Ended December 31,   2024  2023 Current income taxes:      Federal $-  $- State and local  (169)  (98)Foreign  (43)  - Total current  (212)  (98)         Deferred income taxes:        Federal  -   - State and local  -   - Total